Featured Research

from universities, journals, and other organizations

Brain Scans Detect Earliest Stages Of Alzheimer's Disease

Date:
January 5, 1999
Source:
New York University Medical Center And School Of Medicine
Summary:
New York University School of Medicine researchers have found a way to gauge the earliest signs of Alzheimer's Disease in the brain. Their technique may provide a better tool to diagnose the dementia-producing disease years before a person experiences any memory loss.

New York University School of Medicine researchers have found a way to gauge the earliest signs of Alzheimer's Disease in the brain. Their technique may provide a better tool to diagnose the dementia-producing disease years before a person experiences any memory loss.

"We have found a way to measure what may be the earliest changes in the memory-processing areas of the brain," says Dr. Mony de Leon, Professor of Psychiatry at NYU School of Medicine. "Our technique can be performed rapidly and potentially may be used to monitor the effect of therapies on the course of Alzheimer's disease," says Dr. de Leon, who is Director of the NYU School of Medicine Neuroimaging Research Laboratory.

In a new study published in the Jan. 2 issue of the journal Lancet, Dr. de Leon and co-workers report that they have measured the anatomical changes in a key memory center of the brain called the entorhinal cortex. They demonstrate through MRI scans that this area shrinks substantially in patients with very mild Alzheimer's compared to healthy volunteers. MRI scans are a powerful imaging tool that rely on electromagnetic energy to excite water molecules in the brain in order to create an anatomical snapshot of the brain.

Alzheimer's is a progressive illness that destroys neurons in the brain initially causing memory loss and eventually dementia. It afflicts some four million older adults in the United States and perhaps three times as many individuals suffer milder forms of the disease that incapacitate memory. It can be diagnosed definitively only after a person dies by an autopsy showing certain brain abnormalities.

Currently, physicians diagnose the disease by evaluating a person's performance on tests of memory and learning, taking a thorough medical and family history, and performing a physical examination. But the disease is difficult to diagnose in its initial stages because there are no definitive laboratory tests.

The new study extends previous findings by Dr. de Leon and other researchers that the hippocampus, another region of the brain associated with memory and learning, diminishes in size as Alzheimer's Disease progresses.

The progressive damage and loss of neurons is one of the hallmarks of Alzheimer's Disease. Previous studies by a German research team indicated that the damage begins in the entorhinal cortex as early as age 30 and spreads to the hippocampus. However, without MRI, this deterioration has been impossible to monitor.

"The entorhinal cortex is the gateway to the hippocampus and is central to all memory functions in the brain," explains Dr. de Leon. "It is a memory distribution and processing center and if its gate is broken, then new memories cannot be made and old memories cannot be retrieved.

In the new study, Dr. de Leon and co-workers developed a new method of measuring the size of the entorhinal cortex based on structural landmarks (called gyri and sulci) which are visible on MRI.

In the first part of the study, the researchers used autopsied brain tissue from Alzheimer's patients and from control subjects who died of conditions unrelated to the brain to establish that the landmarks could be used to define the boundaries of the entorhinal cortex, providing a valid tool for measuring its surface area. The landmark-measurement technique revealed that the entorhinal cortex was reduced by 45% among Alzheimer's patients. In the second part, the researchers used the landmark technique to distinguish patients with very mild Alzheimer's from healthy volunteers. They found that the entorhinal cortex was 27% smaller in patients with very mild Alzheimer's. Moreover, the damage to the entorhinal cortex was greater than to the hippocampus and it proved a more reliable disease marker.

"This is a preliminary study that should be expanded over a period of years to see how brain areas change relative to each other," says Dr. de Leon. "For people with a family history of Alzheimer's, it may be possible to observe such changes and to treat the brain years before there are any signs of memory loss."


Story Source:

The above story is based on materials provided by New York University Medical Center And School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

New York University Medical Center And School Of Medicine. "Brain Scans Detect Earliest Stages Of Alzheimer's Disease." ScienceDaily. ScienceDaily, 5 January 1999. <www.sciencedaily.com/releases/1999/01/990105080006.htm>.
New York University Medical Center And School Of Medicine. (1999, January 5). Brain Scans Detect Earliest Stages Of Alzheimer's Disease. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/1999/01/990105080006.htm
New York University Medical Center And School Of Medicine. "Brain Scans Detect Earliest Stages Of Alzheimer's Disease." ScienceDaily. www.sciencedaily.com/releases/1999/01/990105080006.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins